MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. Navigating these changes can create uncertainty in the industry and affect patient access.

Legislation 52

Legislation Law Marijuana Dispensary 52

MMJ Recs

MARCH 28, 2024

Look for experience in treating conditions eligible for MMJ treatment under Iowa law, such as chronic pain or epilepsy. Accessibility and responsiveness to patient inquiries and concerns are also crucial. Conduct thorough research on prospective doctors, including their qualifications, experience, and patient reviews.

Patients 52

Patients Treatment Research and Development Therapy 52

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

MARCH 24, 2020

Governors and legislative leaders urged to preserve and ensure cannabis access amid social distancing. The Epilepsy Foundation signed onto the medical letter. The Marijuana Policy Project is tracking state measures to preserve access in light of COVID-19 here. Washington, D.C. — Statement from Laura Weidner, Esq.,

Law 53

Law Epilepsy Treatment Access 53

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JUNE 26, 2019

” She further directly advises that cannabis, or marijuana, is a medicine that an overwhelming majority of Floridians voted for and are constitutionally guaranteed access to as a therapeutic medicine. Dr. Weiner is certified in Interventional Pain Management and Physical Medicine and Rehabilitation. Dr. Michelle Weiner.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub. The club now has 3,000 members nationwide. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 22, 2019

Mr Plamandon said he successfully brought Thai-prescribed cannabis products into WA to treat his chronic pain on April 8. The rules don’t specify the country of origin of the prescription, but they do require travellers to have accessed the drug through a pharmacist.

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Cannabinoids have been assessed for chronic pain management. Several studies indicate smoked THC and nabiximols were both associated with pain reduction. and 2.3%, respectively.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40